Florida Trim Clinic · Education & Evidence

MEDICAL SOURCES & FURTHER READING

Each link below identifies the topic it supports. Sources describe their own research or educational guidance, not Florida Trim Clinic’s services or patient outcomes. Their inclusion does not imply endorsement, affiliation or sponsorship.

  • NIH / National Institute of Diabetes and Digestive and Kidney Diseases

    Factors Affecting Weight & Health

    Supports: The roles of lifestyle, sleep, medicines, health conditions, family history and genes in body weight.

  • Mayo Clinic

    Prescription weight-loss drugs

    Supports: Prescription weight-management options, eligibility, lifestyle measures, potential benefits and risks.

  • PubMed / New England Journal of Medicine

    Once-Weekly Semaglutide in Adults with Overweight or Obesity

    Supports: Weight loss and gastrointestinal adverse events with semaglutide 2.4 mg plus lifestyle intervention in the STEP 1 trial population, not clinic-specific or compounded-drug outcomes.

  • PubMed / New England Journal of Medicine

    Tirzepatide Once Weekly for the Treatment of Obesity

    Supports: Dose-specific weight-loss results and gastrointestinal adverse events in SURMOUNT-1 participants with obesity without diabetes, not guaranteed results or evidence for compounded versions.

RESEARCH & REFERENCES
  1. Once-Weekly Semaglutide in Adults with Overweight or Obesity

    Wilding JPH, Batterham RL, Calanna S, et al. New England Journal of Medicine. 2021.

    Research published in New England Journal of Medicine reported greater weight reduction with semaglutide plus lifestyle intervention than with placebo in adults with overweight or obesity without diabetes. Gastrointestinal adverse events were common. Trial findings are not a prediction of an individual patient's result.

  2. Tirzepatide Once Weekly for the Treatment of Obesity

    Jastreboff AM, Aronne LJ, Ahmad NN, et al. New England Journal of Medicine. 2022.

    Research published in New England Journal of Medicine reported weight reduction with tirzepatide compared with placebo in adults with obesity without diabetes. Gastrointestinal adverse events occurred, particularly during dose escalation. Outcomes depend on the population, treatment and dose studied.

Florida Trim Clinic’s educational information is general and is not individualized medical advice. Prescription treatment requires evaluation by a licensed provider. Eligibility, medication selection and dosing depend on individual circumstances.

Our Origin

Where It All Began

South Florida Trim Clinic in Naples was the first location and the origin of the Trim Clinic Network. It started with licensed medical providers, personalized care, and no membership fees, ever.

Prescription care requires an evaluation by a licensed provider, and treatment is offered only where it is clinically appropriate and you are eligible.

Read the founder’s story